NASDAQ: PROF
Profound Medical Corp Stock Ownership - Who owns Profound Medical?

Insider buying vs selling

Have Profound Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arun Swarup MenawatCEO2025-05-1612,027$4.73
$56.89kBuy
Arun Swarup MenawatCEO2025-05-1510,003$4.33
$43.26kBuy

1 of 1

PROF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PROF insiders and whales buy or sell their stock.

PROF Shareholders

What type of owners hold Profound Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fil Ltd6.04%1,815,000$11.87MInstitution
Gagnon Securities LLC5.65%1,697,680$11.10MInstitution
Letko Brosseau Associates Inc4.02%1,207,850$7.90MInstitution
Timelo Investment Management Inc3.30%990,995$6.48MInstitution
Gagnon Advisors LLC2.98%896,671$5.86MInstitution
Raymond James Financial Inc2.97%892,879$5.84MInstitution
Royce Associates LP2.53%761,799$4.98MInstitution
Rosalind Advisors Inc2.30%692,185$4.53MInstitution
Arun Swarup Menawat1.95%587,089$3.84MInsider
Mmcap International Inc Spc1.60%480,859$3.14MInstitution

1 of 3

PROF vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PROF42.71%1.95%Net BuyingNet Buying
TLSI8.11%54.76%Net BuyingNet Buying
BDMD1.00%17.26%
BWAY15.91%0.00%
SGHT31.66%58.56%Net BuyingNet Buying

Profound Medical Stock Ownership FAQ

Who owns Profound Medical?

Profound Medical (NASDAQ: PROF) is owned by 42.71% institutional shareholders, 1.95% Profound Medical insiders, and 55.34% retail investors. Arun Swarup Menawat is the largest individual Profound Medical shareholder, owning 587,089.00 shares representing 1.95% of the company. Arun Swarup Menawat's Profound Medical shares are currently valued at $3.84M.

If you're new to stock investing, here's how to buy Profound Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.